Circulation Research, Vol 74, 565-575, Copyright © 1994 by American Heart Association

ARTICLES

Lysophosphatidylcholine in oxidized low-density lipoprotein increases endothelial susceptibility to polymorphonuclear leukocyte-induced endothelial dysfunction in porcine coronary arteries. Role of protein kinase C

S Sugiyama, K Kugiyama, M Ohgushi, K Fujimoto and H Yasue
Division of Cardiology, Kumamoto University School of Medicine, Japan.

We have shown that transferred lysophosphatidylcholine (lysoPC) from oxidized low-density lipoprotein (Ox-LDL) to endothelial surface membrane activates protein kinase C (PKC) in endothelial cells, suggesting that Ox-LDL could alter endothelial functions through PKC activation. The purposes of the present study were to examine whether the endothelial susceptibility to polymorphonuclear leukocytes (PMNs) may be altered in Ox-LDL-treated coronary arteries, which have properties closely resembling those observed in atherosclerotic arteries, and to determine the mechanism(s) by which Ox-LDL may affect the endothelial susceptibility to PMNs. Isolated porcine coronary arteries were cannulated and perfused with oxygenated culture medium with or without LDLs or lipids at a constant flow (37 degrees C, pH 7.4). The treatment of porcine coronary arteries with Ox-LDL increased endothelial adhesiveness to PMNs and augmented PMN-induced impairment of endothelium-dependent arterial relaxation (EDR). Furthermore, Ox-LDL stimulated the expression of intercellular adhesion molecule-1 (ICAM-1) in the porcine coronary arterial endothelium. These effects of Ox-LDL were not mediated by the scavenger-receptor-mediated process but were attributed to lysoPC in Ox-LDL. Blocking of the PMN adherence to endothelium by using anti-CD18 monoclonal antibody abolished the PMN- induced impairment of EDR. Coincubation with staurosporine or calphostin C, inhibitors of PKC, during treatment of the arteries with Ox-LDL or lysoPC attenuated the augmentative effects of Ox-LDL and lysoPC on endothelial ICAM-1 expression, endothelial adhesiveness to PMNs, and PMN-induced EDR impairment. Treatment of the arteries with phorbol 12-myristate 13-acetate, a potent stimulator of PKC, induced ICAM-1 expression and enhanced the endothelial adhesiveness to PMNs and PMN-induced EDR impairment, mimicking the effects of Ox-LDL. These results suggest that lysoPC in Ox-LDL induces endothelial ICAM-1 expression, which facilitates PMN adherence to endothelium and the subsequent augmentation of PMN-induced EDR impairment. PKC activation in endothelial cells by lysoPC in Ox-LDL may at least in part be involved in these effects of Ox-LDL. LysoPC in Ox-LDL increases endothelial susceptibility to PMN-induced endothelial dysfunction.

This article has been cited by other articles:

				R. P. Brandes Roads to Dysfunction: Argininase II Contributes to Oxidized Low-Density Lipoprotein-Induced Attenuation of Endothelial NO Production Circ. Res., October 27, 2006; 99(9): 918 - 920. [Full Text] [PDF]

				C. Rask-Madsen and G. L. King Proatherosclerotic Mechanisms Involving Protein Kinase C in Diabetes and Insulin Resistance Arterioscler Thromb Vasc Biol, March 1, 2005; 25(3): 487 - 496. [Abstract] [Full Text] [PDF]

				H. Lum, J. Qiao, R. J. Walter, F. Huang, P. V. Subbaiah, K. S. Kim, and O. Holian Inflammatory stress increases receptor for lysophosphatidylcholine in human microvascular endothelial cells Am J Physiol Heart Circ Physiol, October 1, 2003; 285(4): H1786 - H1789. [Abstract] [Full Text] [PDF]

				C. C. Silliman, D. J. Elzi, D. R. Ambruso, R. J. Musters, C. Hamiel, R. J. Harbeck, A. J. Paterson, A. J. Bjornsen, T. H. Wyman, M. Kelher, et al. Lysophosphatidylcholines prime the NADPH oxidase and stimulate multiple neutrophil functions through changes in cytosolic calcium J. Leukoc. Biol., April 1, 2003; 73(4): 511 - 524. [Abstract] [Full Text] [PDF]

				Y. Rikitake, S. Kawashima, T. Takahashi, T. Ueyama, S. Ishido, N. Inoue, K.-I. Hirata, and M. Yokoyama Regulation of tyrosine phosphorylation of PYK2 in vascular endothelial cells by lysophosphatidylcholine Am J Physiol Heart Circ Physiol, July 1, 2001; 281(1): H266 - H274. [Abstract] [Full Text] [PDF]

				M. Morimoto, N. Kume, S. Miyamoto, Y. Ueno, H. Kataoka, M. Minami, K. Hayashida, N. Hashimoto, and T. Kita Lysophosphatidylcholine Induces Early Growth Response Factor-1 Expression and Activates the Core Promoter of PDGF-A Chain in Vascular Endothelial Cells Arterioscler Thromb Vasc Biol, May 1, 2001; 21(5): 771 - 776. [Abstract] [Full Text] [PDF]

				Y. Rikitake, S. Kawashima, T. Yamashita, T. Ueyama, S. Ishido, H. Hotta, K.-i. Hirata, and M. Yokoyama Lysophosphatidylcholine Inhibits Endothelial Cell Migration and Proliferation via Inhibition of the Extracellular Signal-Regulated Kinase Pathway Arterioscler Thromb Vasc Biol, April 1, 2000; 20(4): 1006 - 1012. [Abstract] [Full Text] [PDF]

				T. Tanaka, M. Kurabayashi, Y. Aihara, Y. Ohyama, and R. Nagai Inducible Expression of Manganese Superoxide Dismutase by Phorbol 12-Myristate 13-Acetate Is Mediated by Sp1 in Endothelial Cells Arterioscler Thromb Vasc Biol, February 1, 2000; 20(2): 392 - 401. [Abstract] [Full Text] [PDF]

				S. Parthasarathy, N. Santanam, S. Ramachandran, and O. Meilhac Oxidants and antioxidants in atherogenesis: an appraisal J. Lipid Res., December 1, 1999; 40(12): 2143 - 2157. [Abstract] [Full Text] [PDF]

				B. Frei On the Role of Vitamin C and Other Antioxidants in Atherogenesis and Vascular Dysfunction Experimental Biology and Medicine, December 1, 1999; 222(3): 196 - 204. [Abstract] [Full Text]

				B. V. Bassa, D. D. Roh, N. D. Vaziri, M. A. Kirschenbaum, and V. S. Kamanna Lysophosphatidylcholine activates mesangial cell PKC and MAP kinase by PLCgamma -1 and tyrosine kinase-Ras pathways Am J Physiol Renal Physiol, September 1, 1999; 277(3): F328 - F337. [Abstract] [Full Text] [PDF]

				A. M Dart and J. P.F Chin-Dusting Lipids and the endothelium Cardiovasc Res, August 1, 1999; 43(2): 308 - 322. [Abstract] [Full Text] [PDF]

				S. Eligini, S. Colli, F. Basso, L. Sironi, and E. Tremoli Oxidized Low Density Lipoprotein Suppresses Expression of Inducible Cyclooxygenase in Human Macrophages Arterioscler Thromb Vasc Biol, July 1, 1999; 19(7): 1719 - 1725. [Abstract] [Full Text] [PDF]

				A. Gómez-Muñoz, L. O'Brien, R. Hundal, and U. P. Steinbrecher Lysophosphatidylcholine stimulates phospholipase D activity in mouse peritoneal macrophages J. Lipid Res., June 1, 1999; 40(6): 988 - 993. [Abstract] [Full Text]

				K. Kugiyama, T. Motoyama, H. Doi, H. Kawano, N. Hirai, H. Soejima, Y. Miyao, K. Takazoe, Y. Moriyama, Y. Mizuno, et al. Improvement of endothelial vasomotor dysfunction by treatment with alpha-tocopherol in patients with high remnant lipoproteins levels J. Am. Coll. Cardiol., May 1, 1999; 33(6): 1512 - 1518. [Abstract] [Full Text] [PDF]

				M. Sata and K. Walsh Endothelial Cell Apoptosis Induced by Oxidized LDL Is Associated with the Down-regulation of the Cellular Caspase Inhibitor FLIP J. Biol. Chem., December 11, 1998; 273(50): 33103 - 33106. [Abstract] [Full Text] [PDF]

				P. Schratzberger, S. Dunzendorfer, N. Reinisch, C. M Kahler, M. Herold, and C. J Wiedermann Release of chemoattractants for human monocytes from endothelial cells by interaction with neutrophils Cardiovasc Res, May 1, 1998; 38(2): 516 - 521. [Abstract] [Full Text] [PDF]

				S. Sugiyama, K. Kugiyama, N. Ogata, H. Doi, Y. Ota, M. Ohgushi, T. Matsumura, H. Oka, and H. Yasue Biphasic Regulation of Transcription Factor Nuclear Factor-{kappa}B Activity in Human Endothelial Cells by Lysophosphatidylcholine Through Protein Kinase C–Mediated Pathway Arterioscler Thromb Vasc Biol, April 1, 1998; 18(4): 568 - 576. [Abstract] [Full Text] [PDF]

				M. Liu, R. W. St. Clair, and P. V. Subbaiah Impaired function of lecithin:cholesterol acyltransferase in atherosclerosis-susceptible White Carneau pigeons: possible effects on metabolism of oxidized phospholipids J. Lipid Res., February 1, 1998; 39(2): 245 - 254. [Abstract] [Full Text]

				C. L. Watson and M. R. Gold Lysophosphatidylcholine Modulates Cardiac INa via Multiple Protein Kinase Pathways Circ. Res., September 19, 1997; 81(3): 387 - 395. [Abstract] [Full Text]

				J. Goyal, K. Wang, M. Liu, and P. V. Subbaiah Novel Function of Lecithin-Cholesterol Acyltransferase. HYDROLYSIS OF OXIDIZED POLAR PHOSPHOLIPIDS GENERATED DURING LIPOPROTEIN OXIDATION J. Biol. Chem., June 27, 1997; 272(26): 16231 - 16239. [Abstract] [Full Text] [PDF]

				L. Liao, R. M. Starzyk, and D. N. Granger Molecular Determinants of Oxidized Low-Density Lipoprotein–Induced Leukocyte Adhesion and Microvascular Dysfunction Arterioscler Thromb Vasc Biol, March 1, 1997; 17(3): 437 - 444. [Abstract] [Full Text]

				K. Kugiyama, S. Sugiyama, T. Matsumura, Y. Ohta, H. Doi, and H. Yasue Suppression of Atherosclerotic Changes in Cholesterol-Fed Rabbits Treated With an Oral Inhibitor of Neutral Endopeptidase 24.11 (EC 3.4.24.11) Arterioscler Thromb Vasc Biol, August 1, 1996; 16(8): 1080 - 1087. [Abstract] [Full Text]

				T. Murohara, R. Scalia, and A. M. Lefer Lysophosphatidylcholine Promotes P-Selectin Expression in Platelets and Endothelial Cells : Possible Involvement of Protein Kinase C Activation and Its Inhibition by Nitric Oxide Donors Circ. Res., May 1, 1996; 78(5): 780 - 789. [Abstract] [Full Text]

				C. L. Cowan and R. P. Steffen Lysophosphatidylcholine Inhibits Relaxation of Rabbit Abdominal Aorta Mediated by Endothelium-Derived Nitric Oxide and Endothelium-Derived Hyperpolarizing Factor Independent of Protein Kinase C Activation Arterioscler Thromb Vasc Biol, December 1, 1995; 15(12): 2290 - 2297. [Abstract] [Full Text]

				S. Sugiyama, K. Kugiyama, T. Matsumura, S.-i. Suga, H. Itoh, K. Nakao, and H. Yasue Lipoproteins Regulate C-Type Natriuretic Peptide Secretion From Cultured Vascular Endothelial Cells Arterioscler Thromb Vasc Biol, November 1, 1995; 15(11): 1968 - 1974. [Abstract] [Full Text]

				T. W. Gauthier, R. Scalia, T. Murohara, J.-p. Guo, and A. M. Lefer Nitric Oxide Protects Against Leukocyte-Endothelium Interactions in the Early Stages of Hypercholesterolemia Arterioscler Thromb Vasc Biol, October 1, 1995; 15(10): 1652 - 1659. [Abstract] [Full Text]

				H. Ochi, N. Kume, E. Nishi, and T. Kita Elevated Levels of cAMP Inhibit Protein Kinase C– Independent Mechanisms of Endothelial Platelet-Derived Growth Factor–B Chain and Intercellular Adhesion Molecule-1 Gene Induction by Lysophosphatidylcholine Circ. Res., September 1, 1995; 77(3): 530 - 535. [Abstract] [Full Text]

				Y. S. Kim, C.-Y. Han, S.-W. Kim, J.-H. Kim, S.-K. Lee, D.-J. Jung, S.-Y. Park, H. Kang, H.-S. Choi, J. W. Lee, et al. The Orphan Nuclear Receptor Small Heterodimer Partner as a Novel Coregulator of Nuclear Factor-kappa B in Oxidized Low Density Lipoprotein-treated Macrophage Cell Line RAW 264.7 J. Biol. Chem., August 31, 2001; 276(36): 33736 - 33740. [Abstract] [Full Text] [PDF]